Hemosiderosis other imaging findings

Hemosiderosis Microchapters
Home
Patient Information
Overview
Historical Perspective
Classification
Pathophysiology
Causes
Differentiating Hemosiderosis from other Diseases
Epidemiology and Demographics
Risk Factors
Screening
Natural History, Complications and Prognosis
Diagnosis
History and Symptoms
Physical Examination
Laboratory Findings
Electrocardiogram
Chest X Ray
CT
MRI
Echocardiography or Ultrasound
Other Imaging Findings
Other Diagnostic Studies
Treatment
Medical Therapy
Surgery
Primary Prevention
Secondary Prevention
Cost-Effectiveness of Therapy
Future or Investigational Therapies
Case Studies
Case #1
Hemosiderosis other imaging findings On the Web
Most recent articles
Most cited articles
Review articles
CME Programs
Powerpoint slides
Images
American Roentgen Ray Society Images of Hemosiderosis other imaging findings All Images X-rays Echo & Ultrasound CT Images MRI
Ongoing Trials at Clinical Trials.gov
US National Guidelines Clearinghouse
NICE Guidance
FDA on Hemosiderosis other imaging findings
CDC on Hemosiderosis other imaging findings
Hemosiderosis other imaging findings in the news
Blogs on Hemosiderosis other imaging findings
Directions to Hospitals Treating Hemosiderosis
Risk calculators and risk factors for Hemosiderosis other imaging findings

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]

Overview

Chromium and technetium based perfusion scans may be helpful in the diagnosis of IPH. Findings on these perfusion scans suggestive of IPH include: abnormal pulmonary uptake 12-24 hours after the injection in patients with pulmonary hemorrhage.

Other imaging findings

Chromium and technetium based perfusion scans may be helpful in the diagnosis of IPH. Findings on these perfusion scans suggestive of IPH include:

• Abnormal pulmonary uptake 12-24 hours after the injection in patients with pulmonary hemorrhage.